KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Inventory: 2009-2025

Historic Inventory for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $302.6 million.

  • Charles River Laboratories International's Inventory fell 10.01% to $302.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $302.6 million, marking a year-over-year decrease of 10.01%. This contributed to the annual value of $278.5 million for FY2024, which is 26.75% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Inventory of $302.6 million as of Q3 2025, which was up 8.23% from $279.6 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Inventory peaked at $380.3 million during Q4 2023, and registered a low of $181.7 million during Q3 2021.
  • Moreover, its 3-year median value for Inventory was $293.0 million (2023), whereas its average is $310.8 million.
  • Its Inventory has fluctuated over the past 5 years, first surged by 48.65% in 2023, then dropped by 26.75% in 2024.
  • Charles River Laboratories International's Inventory (Quarterly) stood at $199.1 million in 2021, then climbed by 28.45% to $255.8 million in 2022, then soared by 48.65% to $380.3 million in 2023, then declined by 26.75% to $278.5 million in 2024, then fell by 10.01% to $302.6 million in 2025.
  • Its last three reported values are $302.6 million in Q3 2025, $279.6 million for Q2 2025, and $290.2 million during Q1 2025.